Atomoxetine for schizophrenia

To examine the effects of atomoxetine on cognitive impairment in people with schizophrenia.

This is a protocol.

Health topics:

Published:

27 March 2014

Authors:

Shahzad Ashraf M, Javed Z, Kumar A

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Shahzad Ashraf M, Javed Z, Kumar A. Atomoxetine for schizophrenia. Cochrane Database of Systematic Reviews 2014, Issue 3. Art. No.: CD011035. DOI: 10.1002/14651858.CD011035